<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2022</study_start_year><condition>Ovarian Cancer</condition><condition>Lung Cancer</condition><condition>Melanoma</condition><condition>Colorectal Cancer</condition><condition>Prostate Cancer</condition><condition>Chronic Leukemia</condition><condition>Breast Cancer</condition><condition>Tyrosine Kinase Mutation</condition><condition>Cancer</condition><condition>Multiple Myeloma</condition><disease>Ovarian Cancer</disease><disease>Lung Cancer</disease><disease>Melanoma</disease><disease>Colorectal Cancer</disease><disease>Prostate Cancer</disease><disease>Chronic Leukemia</disease><disease>Breast Cancer</disease><disease>Tyrosine Kinase Mutation</disease><disease>Multiple Myeloma</disease><disease>Cancer</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/1991</full_dataset_link><location>Canada</location><study_start_month>11</study_start_month><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study</name><description>People with advanced chronic cancers are now living for many years as a result of new targeted anti-cancer treatments. Many of these treatments are quite new and people may take them for months, even years, as long as the treatments are helping. The purpose of this study is to help understand how to best support people receiving these treatments.</description><dates><creation>2022-11-15</creation></dates><accession>1991</accession><cross_references><ClinicalTrials___gov>NCT05645510</ClinicalTrials___gov></cross_references></HashMap>